AAAAAA
Results:
1-10
|
Results: 10
Authors:
Delaugerre, C
Valantin, MA
Mouroux, M
Bonmarchand, M
Carcelain, G
Duvivier, C
Tubiana, R
Simon, A
Bricaire, F
Agut, H
Autran, B
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure, AIDS, 15(16), 2001, pp. 2189-2191
Authors:
Delaugerre, C
Rohban, R
Simon, A
Mouroux, M
Tricot, C
Agher, R
Huraux, JM
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen, J MED VIROL, 65(3), 2001, pp. 445-448
Authors:
Delaugerre, C
Mouroux, M
Yvon-Groussin, A
Simon, A
Angleraud, F
Huraux, JM
Agut, H
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice, ANTIM AG CH, 45(3), 2001, pp. 946-948
Authors:
Carcelain, G
Tubiana, R
Samri, A
Calvez, V
Delaugerre, C
Agut, H
Katlama, C
Autran, B
Citation: G. Carcelain et al., Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection, J VIROLOGY, 75(1), 2001, pp. 234-241
Authors:
Mouroux, M
Izopet, J
Descamps, D
Delaugerre, C
Yvon-Groussin, A
Angleraud, F
Coutellier, A
Bonmarchand, M
Valantin, MA
Matheron, S
Agut, H
Katlama, C
Brun-Vezinet, F
Calvez, V
Citation: M. Mouroux et al., Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T., PATH BIOL, 48(5), 2000, pp. 508-512
Authors:
Descamps, D
Flandre, P
Calvez, V
Peytavin, G
Meiffredy, V
Collin, G
Delaugerre, C
Robert-Delmas, S
Bazin, B
Aboulker, JP
Pialoux, G
Raffi, F
Brun-Vezinet, F
Citation: D. Descamps et al., Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, J AM MED A, 283(2), 2000, pp. 205-211
Authors:
Mouroux, M
Yvon-Groussin, A
Peytavin, G
Delaugerre, C
Legrand, M
Bossi, P
Do, B
Trylesinski, A
Diquet, B
Dohin, E
Delfraissy, JF
Katlama, C
Calvez, V
Citation: M. Mouroux et al., Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance, J CLIN MICR, 38(7), 2000, pp. 2726-2730
Authors:
Combadiere, B
Blanc, C
Li, TS
Carcelain, G
Delaugerre, C
Calvez, V
Tubiana, R
Debre, P
Katlama, C
Autran, B
Citation: B. Combadiere et al., CD4(+)Ki67(+) lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle, EUR J IMMUN, 30(12), 2000, pp. 3598-3603
Authors:
Mouroux, M
Bossi, P
Yvon-Groussin, A
Delaugerre, C
Valantin, MA
Tubiana, R
Coutellier, A
Bonmarchand, M
Bricaire, F
Katlama, C
Agut, H
Huraux, JM
Calvez, V
Citation: M. Mouroux et al., Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor., PATH BIOL, 47(5), 1999, pp. 549-552
Authors:
Servant, A
Bogard, M
Delaugerre, C
Cohen, P
Deny, P
Guillevin, L
Citation: A. Servant et al., GB virus C in systemic medium- and small-vessel necrotizing vasculitides, BR J RHEUM, 37(12), 1998, pp. 1292-1294
Risultati:
1-10
|